STABLE PROTEIN FORMULATIONS

The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tole...

Full description

Saved in:
Bibliographic Details
Main Authors Dahlheim, Charles E, Naringrekar, Vijay H, Borsadia, Sunita, Dali, Manisha M, Nerurkar, Manoj, Gandhi, Rajesh B
Format Patent
LanguageCroatian
English
Published 10.06.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Bibliography:Application Number: HR2013P001196T